This post has expired! It was posted more than 90 days ago.
<- Back

165065 - 23rd Australasian Menopause Society Congress

  • : Online

In 2019, our Congress will be at the Hotel Grand Chancellor in Hobart. Hobart has a cool climate but it is a hot destination, and our Congress will explore the hot issues in menopause. 

We will have national and international speakers presenting up to the minute information on new medications, new drug delivery methods, new treatment methods, and new classifications, in menopausal symptoms, vulvovaginal symptoms, fibroids, breast cancer, and osteoporosis. Discuss and debate what’s new and what’s important in menopause. 

We will also be running our popular Pre-Congress Menopause Essentials Update. This provides a clinically focussed update in all aspects of menopause management. 

Meet colleagues from Australia, New Zealand and beyond.

Relevance to General Practice

External factors like family and socioeconomic concerns will influence how women cope with ageing, chronic illness and discomfort. 
A significant proportion of women are consulting doctors and a large group of them will require primary care advice on the management and treatment of midlife conditions such as mental health, breast cancer, vulvovaginal symptoms, fibroids, and osteoporosis. 
The understanding of how to implement therapies and treatments is poorly understood and as a consequence women’s midlife symptoms are either overlooked or inadequately managed. General practices must start to explore and implement new relevant medications, drug delivery methods, treatment methods, and classifications. 
Based on the above data it is important that an educational activity be developed to provide strategies to manage these issue issues in the most appropriate manner.

Learning outcomes
  • List the effects of hormone therapy on cognition and risk of Alzheimer's disease
  • Discuss potential treatments for cognitive symptoms and neuropsychological impairment in cancer survivors
  • Implement the available guidelines on abnormal vaginal bleeding
  • Discuss the FDA warning and findings of the Australian Senate Inquiry into the use of mesh for prolapse
  • List the pros and cons for the use of progesterone receptor modulators in the use of fibroids
  • Delivery
    165065 - 23rd Australasian Menopause Society Congress
    13 hours
    Start Date
    End Date
    CPD Points
    13 hours
    Contact Phone
    Log in into view this field.
    Location Map View Map